Show simple item record

dc.contributor.authorIslam, Md. Shahidulen_US
dc.contributor.authorLoots, Du Toit
dc.date.accessioned2010-08-04T15:37:33Z
dc.date.available2010-08-04T15:37:33Z
dc.date.issued2009en_US
dc.identifier.citationIslam, M.S. & Loots, D.T. 2009. Experimental rodent models of type 2 diabetes: a review. Methods and findings in experimental and clinical pharmacology, 31(4):249-261. [http://dx.doi.org/10.1358/mf.2009.31.4.1362513]en_US
dc.identifier.issn0379-0355
dc.identifier.urihttp://hdl.handle.net/10394/3484
dc.identifier.urihttp://dx.doi.org/10.1358/mf.2009.31.4.1362513
dc.description.abstractDue to the high prevalence of diabetes worldwide, extensive research is still being performed to develop new antidiabetic agents and determine their mechanisms of action. Consequently, a number of diabetic animal models have been developed and improved over the years, of which rodent models are the most thoroughly described. These rodent models can be classified into two broad categories: 1) genetically induced spontaneous diabetes models; and 2) experimentally induced nonspontaneous diabetes models. The popularity of using experimentally induced nonspontaneous models for diabetes research over that of the genetically induced spontaneous models is due to their comparatively lower cost, ease of diabetes induction, ease of maintenance and wider availability. The various experimentally induced type 2 diabetes (T2D) rodent models developed over the last 30-plus years for both routine pharmacological screening and mechanistic diabetes-linked research trials include: adult streptozotocin (STZ)/alloxan rat models, neonatal STZ/alloxan models, partial pancreatectomy models, long-term high-fat (HF) diet-fed models, HF diet-fed STZ models, nicotinamide/STZ models, intrauterine growth retardation (IUGR) models, the STZ-induced progressive diabetic model and monosodium glutamate (MSG)-induced model. The use of these models, however, is not without limitations. A T2D model should ideally portray an identical biochemical blood profile and pathogenesis to T2D in humans. Hence, this review will comparatively evaluate experimentally induced rodent T2D models considering the above-mentioned criteria, in order to guide diabetes research groups to more accurately select the most appropriate models given their specific research requirements
dc.publisherThomson Reuters
dc.subjectType 2 diabetes model
dc.subjectStreptozotocin
dc.subjectNicotinamide
dc.subjectHigh-fat diet
dc.subjectIntrauterine growth retardation
dc.subjectRats
dc.subjectMice
dc.titleExperimental rodent models of type 2 diabetes: a reviewen_US
dc.contributor.researchID10799508 - Loots, Du Toit


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record